Published in PLoS One on June 30, 2014
Role of microRNA-4458 in patients with non-small-cell lung cancer. Oncol Lett (2016) 0.75
Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma. Oncol Lett (2016) 0.75
Overexpressed somatic alleles are enriched in functional elements in Breast Cancer. Sci Rep (2017) 0.75
Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc (2009) 15.16
Retracted A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell (2009) 10.51
Multidisciplinary management of lung cancer. N Engl J Med (2004) 7.13
CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol (1994) 4.62
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology (2008) 4.38
Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell (2012) 2.53
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer (2010) 2.20
miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem (2010) 2.05
A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res (2011) 1.82
Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother (2010) 1.82
Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol (2010) 1.80
Retracted Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res (2010) 1.73
miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer (2012) 1.72
PIK3CA mutation and amplification in human lung cancer. Pathol Int (2007) 1.55
Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res (2012) 1.55
Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res (2002) 1.53
Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res (2007) 1.34
Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One (2010) 1.27
Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol (2009) 1.26
Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer (2011) 1.24
Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol (2009) 1.24
Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. Lung Cancer (2009) 1.22
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res (2013) 1.17
miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol Cell Biol (2010) 1.15
Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int J Cancer (2011) 1.11
miR-31 is a broad regulator of β1-integrin expression and function in cancer cells. Mol Cancer Res (2011) 1.05
Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J Pathol (1999) 1.01
KRAS gene mutations in lung cancer: particulars established and issues unresolved. Pathol Int (2010) 1.00
C/EBP alpha mutations in lung cancer. Lung Cancer (2006) 0.96
Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590. Lung Cancer (2007) 0.89
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Lung Cancer (2002) 0.89
Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis. Am J Pathol (2009) 0.87
Pulmonary Neoplasms in Patients with Birt-Hogg-Dubé Syndrome: Histopathological Features and Genetic and Somatic Events. PLoS One (2016) 0.80
Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma. Asia Pac J Clin Oncol (2016) 0.78
Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence. Oncotarget (2016) 0.75
Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report. Diagn Pathol (2016) 0.75
Reply to: 'Management of cardiac metastasis from renal carcinoma 11 yeaers after radical nephrectomy' by D Charbit et al. Asian Cardiovasc Thorac Ann (2014) 0.75
The potential role of microRNA-31 expression in early colorectal cancer. Pathol Int (2015) 0.75
Microcarcinoid arising in patients with long standing ulcerative colitis: histological analysis. Hum Pathol (2017) 0.75
Role of 3'-phosphoinositides in oncogenic KRAS-induced modulation of shape and motility of airway epithelial cells. Pathol Int (2009) 0.75
Late cardiac metastasis from colorectal carcinoma 15 years after surgery. Asian Cardiovasc Thorac Ann (2014) 0.75
Primary Cutaneous NK/T-cell Lymphoma of Nasal Type: An Age-related Lymphoproliferative Disease? Hum Pathol (2017) 0.75
Case of adult-onset verrucous hemangioma developed after repeated trauma. J Dermatol (2015) 0.75
A method to obtain reproducible Ki-67 indexes in lung adenocarcinoma. Histopathology (2020) 0.75
Relationship between non-TRU lung adenocarcinomas and bronchiolar metaplasia - potential implication in their histogenesis. Histol Histopathol (2017) 0.75
Alterations in cathepsin L expression in lung cancers. Pathol Int (2016) 0.75
The Pathological Features of Idiopathic Interstitial Pneumonia - Associated Pulmonary Adenocarcinomas. Histopathology (2016) 0.75